{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:37:50Z","timestamp":1790080670349,"version":"4.0.1"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2016,12,8]]},"DOI":"10.18632\/aging.101121","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T20:25:42Z","timestamp":1481401542000},"page":"3321-3340","source":"Crossref","is-referenced-by-count":36,"title":["RelA NF-\u03baB subunit activation as a therapeutic target in diffuse large B-cell lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Mingzhi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital Zhengzhou University, Zhengzhou, Henan, China"},{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun Y.","family":"Xu-Monette","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiraju C.","family":"Manyam","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"University Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[{"name":"Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[{"name":"The Methodist Hospital, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center and New York Presbyterian Hospital, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy L.","family":"Richards","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill, NC 27514, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.L.","family":"Choi","sequence":"additional","affiliation":[{"name":"University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Han van Krieken","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[{"name":"Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"San Raffaele H. Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[{"name":"San Raffaele H. Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben M.","family":"Parsons","sequence":"additional","affiliation":[{"name":"Gundersen Medical Foundation, La Crosse, WI 54601, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane N.","family":"Winter","sequence":"additional","affiliation":[{"name":"Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Hospital Universitario Marques de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan V.","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"The University of Texas School of Medicine, Graduate School of Biomedical Sciences, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/blood-2005-02-0687","article-title":"Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.","volume":"10","author":"Shipp","year":"2005","journal-title":"Blood"},{"key":"2","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.","volume":"2","author":"Connors","year":"2005","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"40","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"4","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.","volume":"19","author":"Staudt","year":"2001","journal-title":"J Exp Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.1008969108","article-title":"Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells.","volume":"10","author":"Krappmann","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era.","volume":"1","author":"Wilson","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker.","volume":"1","author":"Karin","year":"2011","journal-title":"Nat Immunol"},{"key":"8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/modpathol.2014.34","article-title":"NF\u03baB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.","volume":"2","author":"Piris","year":"2014","journal-title":"Mod Pathol"},{"key":"9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2559.2008.03139.x","article-title":"Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.","volume":"5","author":"Prat","year":"2008","journal-title":"Histopathology"},{"key":"10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/modpathol.2015.76","article-title":"Evaluation of NF-\u03baB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.","volume":"2","author":"Zu","year":"2015","journal-title":"Mod Pathol"},{"key":"11","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation.","volume":"1","author":"Ghosh","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.","volume":"46","author":"Wright","year":"2010","journal-title":"Nature"},{"key":"13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2009.137","article-title":"The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives.","volume":"2","author":"Lenardo","year":"2010","journal-title":"Cell Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1038\/sj.onc.1209934","article-title":"IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.","volume":"2","author":"Scheidereit","year":"2006","journal-title":"Oncogene"},{"key":"15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/34356","article-title":"Crystal structure of p50\/p65 heterodimer of transcription factor NF-kappaB bound to DNA.","volume":"39","author":"Ghosh","year":"1998","journal-title":"Nature"},{"key":"16","first-page":"2117","article-title":"NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity.","volume":"12","author":"Israel","year":"1996","journal-title":"Development"},{"key":"17","first-page":"1159","article-title":"Activation of NF-kappaB p50\/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression.","volume":"1","author":"Doppler","year":"2000","journal-title":"FASEB J"},{"key":"18","doi-asserted-by":"publisher","first-page":"23157","DOI":"10.18632\/oncotarget.4319","article-title":"Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.","volume":"6","author":"Zu","year":"2015","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1128\/MCB.13.12.7826","article-title":"A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization.","volume":"1","author":"Ballard","year":"1993","journal-title":"Mol Cell Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0969-2126(00)00123-4","article-title":"NF-kappaB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets.","volume":"8","author":"Ghosh","year":"2000","journal-title":"Structure"},{"key":"21","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.1038\/ncomms8068","article-title":"I\u03baB\u03b2 enhances the generation of the low-affinity NF\u03baB\/RelA homodimer.","volume":"6","author":"Hoffmann","year":"2015","journal-title":"Nat Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.cdd.4401877","article-title":"NF-kappaB and IKK as therapeutic targets in cancer.","volume":"1","author":"Baldwin","year":"2006","journal-title":"Cell Death Differ"},{"key":"23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.","volume":"10","author":"Baldwin","year":"2001","journal-title":"J Clin Invest"},{"key":"24","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-kappaB pathways in hematological malignancies. Cellular and molecular life sciences.","volume":"7","author":"Zauli","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1535-6108(02)00068-5","article-title":"p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.","volume":"1","author":"Verma","year":"2002","journal-title":"Cancer Cell"},{"key":"26","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1096\/fj.10-160549","article-title":"p53 and NF-\u03baB: different strategies for responding to stress lead to a functional antagonism.","volume":"2","author":"Levine","year":"2010","journal-title":"FASEB J"},{"key":"27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2007.02.019","article-title":"Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.","volume":"2","author":"Chen","year":"2007","journal-title":"Mol Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ncb1724","article-title":"p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.","volume":"1","author":"Tanaka","year":"2008","journal-title":"Nat Cell Biol"},{"key":"29","doi-asserted-by":"publisher","first-page":"52141","DOI":"10.1074\/jbc.M407915200","article-title":"Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.","volume":"27","author":"Zhou","year":"2004","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1097-2765(04)00131-5","article-title":"Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.","volume":"1","author":"Perkins","year":"2004","journal-title":"Mol Cell"},{"key":"31","doi-asserted-by":"publisher","first-page":"26115","DOI":"10.1074\/jbc.M313509200","article-title":"p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.","volume":"27","author":"Greene","year":"2004","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/onc.2010.46","article-title":"Cross talk between stimulated NF-kappaB and the tumor suppressor p53.","volume":"2","author":"Kr\u00e4mer","year":"2010","journal-title":"Oncogene"},{"key":"33","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1158\/0008-5472.CAN-13-1070","article-title":"p53 and NF-\u03baB coregulate proinflammatory gene responses in human macrophages.","volume":"7","author":"Resnick","year":"2014","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.humpath.2014.06.032","article-title":"Clinicopathological implications of nuclear factor \u03baB signal pathway activation in diffuse large B-cell lymphoma.","volume":"4","author":"Hou","year":"2015","journal-title":"Hum Pathol"},{"key":"35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/path.2864","article-title":"The biological and clinical impact of inhibition of NF-\u03baB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).","volume":"22","author":"Al-Kuraya","year":"2011","journal-title":"J Pathol"},{"key":"36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.acthis.2012.06.001","article-title":"Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China.","volume":"11","author":"Chen","year":"2013","journal-title":"Acta Histochem"},{"key":"37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas.","volume":"3","author":"Staudt","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"38","doi-asserted-by":"publisher","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-kappaB.","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.","volume":"12","author":"Richards","year":"2012","journal-title":"Blood"},{"key":"40","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.","volume":"12","author":"Chiu","year":"2013","journal-title":"Blood"},{"key":"41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.","volume":"2","author":"van Krieken","year":"2014","journal-title":"Mod Pathol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/modpathol.2015.118","article-title":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.","volume":"2","author":"Chiu","year":"2015","journal-title":"Mod Pathol"},{"key":"43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni.2886","article-title":"The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells.","volume":"1","author":"Kawamura","year":"2014","journal-title":"Nat Immunol"},{"key":"44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2010-06-290437","article-title":"Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-\u03baB-inducing kinase while activating both canonical and alternative nuclear factor-\u03baB pathways.","volume":"11","author":"Ford","year":"2011","journal-title":"Blood"},{"key":"45","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.","volume":"11","author":"Wilson","year":"2009","journal-title":"Blood"},{"key":"46","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1182\/blood-2002-01-0151","article-title":"Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.","volume":"10","author":"Fujii","year":"2002","journal-title":"Blood"},{"key":"47","doi-asserted-by":"publisher","first-page":"28556","DOI":"10.1074\/jbc.M111.256180","article-title":"Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase\/Akt pathway.","volume":"28","author":"Shakibaei","year":"2011","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/asheducation-2013.1.584","article-title":"Treatment strategies for aggressive lymphomas: what works?","volume":"201","author":"Wilson","year":"2013","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"49","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.","volume":"2","author":"Dybk\u00e6r","year":"2012","journal-title":"Leukemia"},{"key":"50","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1182\/blood-2009-12-257378","article-title":"An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.","volume":"11","author":"Ford","year":"2010","journal-title":"Blood"},{"key":"51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.","volume":"17","author":"Ford","year":"2003","journal-title":"J Immunol"},{"key":"52","article-title":"NF-\u03baB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.","author":"Young","year":"2016","journal-title":"Blood Rev"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:34:26Z","timestamp":1599064466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12,31]]}},"alternative-id":["101121","27941215"],"URL":"https:\/\/doi.org\/10.18632\/aging.101121","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}